Podatki
-
AXTI Stock Jumps 7.4% to $47.59 on Heavy Volume
AXTI shares jumped 7.4% to $47.59 with no confirmed catalyst, as volume ran 16% above average following a sequential revenue recovery in Q4. The post AXTI Stock Jumps 7.4% to $47.59 on Heavy Volume first appeared on Alphastreet.
AlphaStreet
2026-03-11, 19:57
-
CNC Stock Plunges 16% on ACA Enrollment Cliff Concerns Impacting Profitability
CNC shares plunge 16% as investor concerns about ACA enrollment cliff impact on profitability trigger broad-based selling. The post CNC Stock Plunges 16% on ACA Enrollment Cliff Concerns Impacting Profitability first appeared on Alphastreet.
AlphaStreet
2026-03-11, 19:02
-
Minerva Neurosciences, Inc (NERV) Reports Q4 Earnings
**Minerva Neurosciences Reports Q4 2025 Results** The post Minerva Neurosciences, Inc (NERV) Reports Q4 Earnings first appeared on Alphastreet.
AlphaStreet
2026-03-11, 19:10
-
Nio (NIO) Surges 15% After Posting First-Ever Quarterly Profit, Beating EPS Estimates
Nio posts first-ever quarterly profit with Q4 EPS of $0.29 vs $0.05 estimate; shares surge 15% on delivery growth and margin expansion. The post Nio (NIO) Surges 15% After Posting First-Ever Quarterly Profit, Beating EPS Estimates first appeared on Alphastreet.
AlphaStreet
2026-03-11, 19:27
-
Figure Technology (FIGR) Shares Surge 21% Despite Missing Q4 EPS
Figure Technology Solutions missed Q4 EPS estimates by 36% yet shares surged 21% on sequential revenue growth and undisclosed forward catalysts. The post Figure Technology (FIGR) Shares Surge 21% Despite Missing Q4 EPS first appeared on Alphastreet.
AlphaStreet
2026-03-11, 18:38
-
BioNTech (BNTX) Reports Q4 Loss of EUR0.33/Share as COVID Vaccine Revenue Plunges; Founders Exit
BioNTech posts wider-than-expected Q4 loss of $0.33/share as COVID vaccine revenue plunges 24% year-over-year; founders to exit for new mRNA venture. The post BioNTech (BNTX) Reports Q4 Loss of EUR0.33/Share as COVID Vaccine Revenue Plunges; Founders Exit first appeared on Alphastreet.
AlphaStreet
2026-03-11, 18:03
-
Dyne Therapeutics (DYN) Q4 Loss Narrows to $0.73/Share vs $0.76 Estimate, Shares Surge 11.8%
Dyne Therapeutics narrows Q4 loss to $0.73/share vs $0.76 estimate, shares jump 11.8% on improving trajectory and $893M cash position. The post Dyne Therapeutics (DYN) Q4 Loss Narrows to $0.73/Share vs $0.76 Estimate, Shares Surge 11.8% first appeared on Alphastreet.
AlphaStreet
2026-03-11, 18:21
-
HPE Maintains $0.14 Quarterly Dividend With 2.61% Yield; Ex-Dividend Date March 24, 2026
HPE maintains its $0.14 quarterly dividend with a 2.7% yield; ex-date March 24, 2026. The post HPE Maintains $0.14 Quarterly Dividend With 2.61% Yield; Ex-Dividend Date March 24, 2026 first appeared on Alphastreet.
AlphaStreet
2026-03-11, 16:35
-
Broadwind Energy Inc (BWEN) Reports Q4 Earnings
**Broadwind Energy Inc Reports Q4 2025 Results** The post Broadwind Energy Inc (BWEN) Reports Q4 Earnings first appeared on Alphastreet.
AlphaStreet
2026-03-11, 16:02
-
Sprinklr Inc (CXM) Beats Q4 FY26 EPS Estimates
Sprinklr Inc (CXM) delivered Q4 2025 adjusted earnings of $0.10 per share, surpassing analysts' $0.09 forecast (beat by 10.0%). Top-line revenue was $219.1... The post Sprinklr Inc (CXM) Beats Q4 FY26 EPS Estimates first appeared on Alphastreet.
AlphaStreet
2026-03-11, 16:16
-
ATRenew Inc (RERE) Reports Q4 Earnings
**ATRenew Inc Reports Q4 2025 Results** The post ATRenew Inc (RERE) Reports Q4 Earnings first appeared on Alphastreet.
AlphaStreet
2026-03-11, 15:43
-
Cadre Holdings, Inc. (CDRE) Misses Q4 EPS Estimates
**Cadre Holdings Reports Q4 2025 Earnings Miss** The post Cadre Holdings, Inc. (CDRE) Misses Q4 EPS Estimates first appeared on Alphastreet.
AlphaStreet
2026-03-11, 15:06
-
CRISPR Therapeutics (CRSP) Reports Wider Q4 Loss of $1.37/Share on Zero Revenue; Shares Plunge 10%
CRISPR Therapeutics posts wider-than-expected Q4 loss of $1.37/share on zero revenue; shares sink 10% as cash burn accelerates. The post CRISPR Therapeutics (CRSP) Reports Wider Q4 Loss of $1.37/Share on Zero Revenue; Shares Plunge 10% first appeared on Alphastreet.
AlphaStreet
2026-03-11, 15:12
-
Groupon Inc. (GRPN) Misses Q4 EPS Estimates
Groupon Inc (GRPN) posted Q4 2025 gaap EPS of $0.17, falling short of the $0.50 estimate (miss by 66.0%). Top-line revenue was $136.0M. The results mark a ... The post Groupon Inc. (GRPN) Misses Q4 EPS Estimates first appeared on Alphastreet.
AlphaStreet
2026-03-11, 15:17
-
SolarEdge (SEDG) Q4 Loss Narrows to $0.14/Share vs $0.24 Estimate, Stock Jumps 10%
SolarEdge narrows Q4 loss to $0.14/share vs $0.24 estimate, stock jumps 10% despite cautious Q1 guidance of $290M-$320M revenue. The post SolarEdge (SEDG) Q4 Loss Narrows to $0.14/Share vs $0.24 Estimate, Stock Jumps 10% first appeared on Alphastreet.
AlphaStreet
2026-03-11, 15:23
-
Pangaea Logistics Solutions Ltd (PANL) Reports Q4 Earnings
Pangaea Logistics Solutions Ltd (PANL) turned in Q4 2025 gaap EPS of $0.18, undershooting the $0.23 Street estimate (miss by 21.7%). Top-line revenue was $... The post Pangaea Logistics Solutions Ltd (PANL) Reports Q4 Earnings first appeared on Alphastreet.
AlphaStreet
2026-03-11, 15:28
-
Minerva Neurosciences, Inc (NERV) Reports Q4 Earnings
**Minerva Neurosciences Reports Q4 2025 Results** The post Minerva Neurosciences, Inc (NERV) Reports Q4 Earnings first appeared on Alphastreet.
AlphaStreet
2026-03-11, 14:31
-
Acacia Research (ACTG) Returns to Profitability With $0.03 EPS in Q4 2025 on Flat $50.1M Revenue
Acacia Research swings to $0.03 adjusted EPS in Q4 2025, matching prior quarter and reversing year-ago loss, as revenue holds flat at $50.1M. The post Acacia Research (ACTG) Returns to Profitability With $0.03 EPS in Q4 2025 on Flat $50.1M Revenue first appeared on Alphastreet.
AlphaStreet
2026-03-11, 14:33
-
Acacia Research Corp (ACTG) Reports Q4 Earnings
Acacia Research Corp (ACTG) reported fourth-quarter 2025 financial results. Acacia Research Corp (ACTG) posted Q4 2025 adjusted EPS of $0.03. Analyst estim... The post Acacia Research Corp (ACTG) Reports Q4 Earnings first appeared on Alphastreet.
AlphaStreet
2026-03-11, 14:37
-
Acacia Research (ACTG) Q4 Adjusted EPS Surges 122.5% YoY to $0.03, Revenue Reaches $50.1M
Acacia Research reports Q4 adjusted EPS of $0.03, up 122.5% year-over-year, with revenue of $50.1M rising 2.6% from the prior year. The post Acacia Research (ACTG) Q4 Adjusted EPS Surges 122.5% YoY to $0.03, Revenue Reaches $50.1M first appeared on Alphastreet.
AlphaStreet
2026-03-11, 14:37
-
Serve Robotics Inc (SERV) Reports Wider Q4 Loss Than Expected
Serve Robotics Inc (SERV) posted a Q4 2025 adjusted loss of $0.49 per share, wider than the -$0.44 expected loss (12.2% wider). The company generated $161.... The post Serve Robotics Inc (SERV) Reports Wider Q4 Loss Than Expected first appeared on Alphastreet.
AlphaStreet
2026-03-11, 14:51
-
Broadwind Energy (BWEN) Posts Q4 Loss of $0.05/Share, Revenue Climbs 10% to $37M
Broadwind Energy reports Q4 loss of $0.05 per share on revenue of $37M, up 10% year-over-year, with fiscal 2026 guidance of $140-$160M. The post Broadwind Energy (BWEN) Posts Q4 Loss of $0.05/Share, Revenue Climbs 10% to $37M first appeared on Alphastreet.
AlphaStreet
2026-03-11, 14:58
-
Rapport Therapeutics Inc (RAPP) Reports a Wider Loss for Q4 2025
Rapport Therapeutics Inc (RAPP) posted a Q4 2025 gaap loss of $0.72 per share, wider than the -$0.67 expected loss (6.8% wider). The clinical-stage biophar... The post Rapport Therapeutics Inc (RAPP) Reports a Wider Loss for Q4 2025 first appeared on Alphastreet.
AlphaStreet
2026-03-11, 14:15
-
BridgeBio (BBIO) Reports Wider Q4 Loss of $1/Share vs $0.63 Estimate; Stock Surges 13%
BridgeBio posts wider-than-expected Q4 loss of $0.94/share on $154.2M revenue; stock surges 13% despite 50.6% earnings miss. The post BridgeBio (BBIO) Reports Wider Q4 Loss of $1/Share vs $0.63 Estimate; Stock Surges 13% first appeared on Alphastreet.
AlphaStreet
2026-03-11, 14:22
-
Verrica Pharmaceuticals inc (VRCA) Reports Q4 Earnings
**Verrica Pharmaceuticals Reports Q4 2025 Results** The post Verrica Pharmaceuticals inc (VRCA) Reports Q4 Earnings first appeared on Alphastreet.
AlphaStreet
2026-03-11, 14:23